enVVeno Medical Corporation
NVNO
$1.00
$0.033.09%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -6.69M | -4.50M | -6.23M | -5.64M | -4.96M |
Total Depreciation and Amortization | 130.00K | 122.00K | 122.00K | 129.00K | 136.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.52M | 845.00K | 1.14M | 997.00K | 959.00K |
Change in Net Operating Assets | 1.33M | -482.00K | -134.00K | 240.00K | -46.00K |
Cash from Operations | -3.72M | -4.02M | -5.11M | -4.28M | -3.91M |
Capital Expenditure | -5.00K | -- | -4.00K | -9.00K | -14.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 2.83M | 5.20M | -11.05M | 6.23M | 3.99M |
Cash from Investing | 2.82M | 5.20M | -11.06M | 6.22M | 3.97M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | 0.00 | 13.59M | 0.00 |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | 0.00 | 13.59M | 0.00 |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -893.00K | 1.18M | -16.16M | 15.54M | 66.00K |